Clinical trials
Active, not recruiting Phase 1/2 trials in Switzerland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Merck Sharp & Dohme LLC | 2 |
| Amgen | 1 |
| AstraZeneca | 1 |
| Bayer | 1 |
| CatalYm GmbH | 1 |
| Celgene | 1 |
| Children's Oncology Group | 1 |
| Eli Lilly and Company | 1 |
| Immunocore Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms | 4 |
| Breast Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Colonic Neoplasms | 2 |
| Melanoma | 2 |
| Multiple Sclerosis | 2 |
| Small Cell Lung Carcinoma | 2 |
| Stomach Neoplasms | 2 |
| Biliary Tract Neoplasms | 1 |
| Blast Crisis | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.